Phodiclinics (Pty) Ltd & Others and Protector Group Medical Services (Pty) Ltd & Others (122/LM/Dec05) [2007] ZACT 17 (21 February 2007)

Parties

Procedural Posture

Large Merger / Reasons for Unconditional Approval After Contested Hearing

Legal Issues

1. 1 Whether the acquisition of Protector Group assets by Phodiclinics and DJF Defty would substantially lessen competition in relevant markets.
2. 2 Whether the failing firm doctrine applies to justify approval of the merger despite high market concentration.
3. 3 Whether the transaction would result in anti-competitive effects in local markets, specifically the Vaal Triangle and Kathu.

Ratio Decidendi

The Tribunal found that New Protector Group was a failed firm unable to meet its financial obligations or reorganise successfully, and that the liquidator made reasonable good-faith efforts to elicit alternative offers, none of which were unconditional or capable of acceptance. The only viable offer was from Phodiclinics. Absent the acquisition, the assets would likely exit the private hospital market, resulting in loss of essential services. While the merger would result in high market shares and increased tariffs in local markets, particularly the Vaal Triangle, these effects were outweighed by the failing firm factor and the public interest in maintaining hospital services. The...

Court Disposition

Merger approved unconditionally. The acquisition does not substantially lessen competition and is justified under the failing firm doctrine.

Orders

• The large merger involving the acquisition by Phodiclinics (Pty) Ltd and DJF Defty (Pty) Ltd of the assets of New Protector Group Holdings (Pty) Ltd and other target companies is approved unconditionally.
• No conditions are imposed on the transaction.